Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 |
| | 10-K | 10-K | 10-K | 10-K | 10-K/A | 10-K | 10-K | 10-K |
| Revenues: |
| Professional Diagnostics | 2,159.7 | 2,241.4 | 2,369.9 | 2,523.2 | 2,191.4 | 1,756.5 | 1,459.5 | 1,263.5 |
| Other | 142.5 | 129.1 | 118.0 | | | | | |
| Consumer Diagnostics | 74.2 | 85.1 | 89.1 | 85.5 | 93.5 | 95.5 | 97.0 | 137.2 |
| Health Management | | | | | | | | 521.9 |
| Other | | | | | 109.5 | 534.5 | 598.8 | |
| Total revenues [+] | 2,376.3 | 2,455.6 | 2,577.0 | 2,608.6 | 2,394.4 | 2,386.5 | 2,155.3 | 1,922.6 |
| Licensing | 12.0 | 17.0 | 21.1 | 27.2 | | 23.5 | 20.8 | 29.1 |
| Products | 1,883.6 | 1,946.3 | 2,024.0 | 2,048.8 | 1,899.9 | 1,683.1 | 1,472.4 | 1,365.1 |
| Services | 480.8 | 492.3 | 532.0 | 532.6 | 465.9 | 679.9 | 662.2 | 528.5 |
| Revenue growth [+] | -3.2% | -4.7% | -1.2% | 8.9% | 0.3% | 10.7% | 12.1% | 21.5% |
| Professional Diagnostics | -3.6% | -5.4% | -6.1% | 15.1% | 24.8% | 20.4% | 15.5% | 20.2% |
| Other | 10.4% | 9.4% | | | | | | |
| Consumer Diagnostics | -12.9% | -4.4% | 4.3% | -8.6% | -2.1% | -1.6% | -29.3% | -1.2% |
| Health Management | | | | | | | | 33.0% |
| Cost of goods sold [+] | 1,286.5 | 1,347.3 | 1,363.5 | 1,296.5 | 1,148.5 | 1,140.7 | 1,020.8 | 868.4 |
| Cost of product sales | 978.3 | 1,039.1 | 1,063.0 | 1,014.5 | | 795.4 | 688.3 | 619.5 |
| Cost of services | 304.9 | 304.4 | 294.9 | 274.2 | 220.5 | 338.2 | 325.3 | 240.0 |
| Cost of licensing | 3.3 | 3.8 | 5.6 | 7.8 | | 7.0 | 7.1 | 8.9 |
| Gross profit | 1,089.9 | 1,108.3 | 1,213.5 | 1,312.1 | 1,245.9 | 1,245.8 | 1,134.6 | 1,054.2 |
| Gross margin | 45.9% | 45.1% | 47.1% | 50.3% | 52.0% | 52.2% | 52.6% | 54.8% |
| Selling, general and administrative [+] | 966.8 | 808.6 | 966.2 | 1,001.3 | 904.0 | 964.9 | 946.0 | 798.7 |
| Sales and marketing | 403.1 | 434.4 | 513.0 | 566.1 | 556.6 | 565.6 | 499.1 | 441.6 |
| General and administrative | 563.8 | 374.2 | 453.2 | 435.2 | 347.4 | 399.3 | 446.9 | 357.0 |
| Research and development | 112.1 | 119.5 | 144.8 | 159.1 | 181.7 | 150.2 | 133.3 | 112.8 |
| Equity in earnings | 50.5 | 15.5 | 17.5 | 17.4 | 13.2 | 8.5 | 10.6 | 7.6 |
| Other operating expenses | -38.3 | -22.0 | -80.8 | -26.2 | | | | |
| EBITDA [+] | 385.3 | 527.0 | 536.8 | 570.0 | 557.3 | 530.9 | 432.0 | 462.8 |
| EBITDA growth | -26.9% | -1.8% | -5.8% | 2.3% | 5.0% | 22.9% | -6.6% | 39.6% |
| EBITDA margin | 16.2% | 21.5% | 20.8% | 21.8% | 23.3% | 22.2% | 20.0% | 24.1% |
| Depreciation and amortization | 285.6 | 309.3 | 336.0 | 374.7 | 383.9 | 391.6 | 366.2 | 312.4 |
| EBIT [+] | 99.7 | 217.8 | 200.7 | 195.3 | 173.4 | 139.3 | 65.8 | 150.3 |
| EBIT growth | -54.2% | 8.5% | 2.8% | 12.6% | 24.5% | 111.6% | -56.2% | 128.7% |
| EBIT margin | 4.2% | 8.9% | 7.8% | 7.5% | 7.2% | 5.8% | 3.1% | 7.8% |
| Non-recurring items [+] | 34.5 | 72.5 | 88.6 | 31.3 | | 383.6 | 1,006.4 | -3.4 |
| Asset impairment | -3.8 | 50.5 | 7.7 | 5.1 | | 383.6 | 1,006.4 | |
| Loss (gain) on sale of assets | | | | | | | | -3.4 |
| Interest expense | 171.7 | 217.0 | 209.2 | 255.3 | 240.4 | 204.0 | 139.4 | 106.8 |
| Interest expense | 171.7 | 217.0 | 209.2 | 255.3 | 240.4 | 204.0 | 139.4 | 106.8 |
| Other income (expense), net | -46.0 | -12.8 | -20.9 | -28.7 | -2.1 | 282.3 | 12.2 | -6.6 |
| Pre-tax income | -152.4 | -84.5 | -117.9 | -120.0 | -69.1 | -166.0 | -1,067.8 | 40.2 |
| Income taxes | 35.4 | -53.6 | 71.0 | -44.7 | -10.7 | -24.2 | -29.9 | 15.6 |
| Tax rate | | 63.4% | | 37.3% | 15.6% | 14.6% | 2.8% | 38.8% |
| Minority interest | 0.4 | 0.4 | 0.0 | 1.0 | 0.3 | 0.2 | 1.4 | 0.5 |
| Earnings from continuing ops | -159.0 | -37.1 | -192.8 | -80.1 | -21.3 | -131.7 | -1,052.9 | 8.8 |
| Earnings from discontinued ops | | 219.5 | 138.3 | -16.1 | -78.5 | | 11.4 | 1.9 |
| Net income | -159.0 | 182.4 | -54.4 | -96.3 | -99.8 | -131.7 | -1,041.5 | 10.7 |
| Net margin | -6.7% | 7.4% | -2.1% | -3.7% | -4.2% | -5.5% | -48.3% | 0.6% |
| |
| Basic EPS [+] | ($1.83) | ($0.43) | ($2.32) | ($0.98) | ($0.26) | ($1.58) | ($12.47) | $0.11 |
| Growth | 321.4% | -81.3% | 136.5% | 271.9% | -83.3% | -87.3% | -11503.5% | -124.5% |
| Diluted EPS [+] | ($1.83) | ($0.43) | ($2.32) | ($0.98) | ($0.26) | ($1.58) | ($12.47) | $0.11 |
| Growth | 321.4% | -81.3% | 136.5% | 271.9% | -83.3% | -87.3% | -11701.0% | -124.1% |
| |
| Shares outstanding (basic) [+] | 86.8 | 85.4 | 82.9 | 81.5 | 80.6 | 83.1 | 84.4 | 80.6 |
| Growth | 1.6% | 3.0% | 1.7% | 1.2% | -3.1% | -1.6% | 4.8% | 3.6% |
| Shares outstanding (diluted) [+] | 86.8 | 85.4 | 82.9 | 81.5 | 80.6 | 83.1 | 84.4 | 82.0 |
| Growth | 1.6% | 3.0% | 1.7% | 1.2% | -3.1% | -1.6% | 3.0% | 5.4% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|